139 related articles for article (PubMed ID: 7691533)
21. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
[TBL] [Abstract][Full Text] [Related]
22. Developmental toxicity of cyclohexanediaminetetraacetic acid (CDTA) in mice.
Sánchez DJ; Colomina MT; Domingo JL; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):329-40. PubMed ID: 8008982
[TBL] [Abstract][Full Text] [Related]
23. Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.
Miranda ES; Miekeley N; De-Carvalho RR; Paumgartten FJ
Reprod Toxicol; 2006 Apr; 21(3):292-300. PubMed ID: 16271447
[TBL] [Abstract][Full Text] [Related]
24. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
25. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
Gale GR; Smith AB; Jones MM; Singh PK
Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
[TBL] [Abstract][Full Text] [Related]
26. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
[TBL] [Abstract][Full Text] [Related]
27. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
Muran PJ
Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potentials of combined use of DMSA with calcium and ascorbic acid in the treatment of mild to moderately lead intoxicated mice.
Liao Y; Zhang J; Jin Y; Lu C; Li G; Yu F; Zhi X; An L; Yang J
Biometals; 2008 Feb; 21(1):1-8. PubMed ID: 17287888
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice.
Reynolds PR; Schaalje GB; Seegmiller RE
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):168-73. PubMed ID: 12797458
[TBL] [Abstract][Full Text] [Related]
30. Variability in the embryotoxicity and fetotoxicity of vanadate with the day of exposure.
Bosque MA; Domingo JL; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Feb; 35(1):1-3. PubMed ID: 8434440
[TBL] [Abstract][Full Text] [Related]
31. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
33. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
[TBL] [Abstract][Full Text] [Related]
34. Dimercaptosuccinic acid loading test for assessing mercury burden in healthy individuals.
Archbold GP; McGuckin RM; Campbell NA
Ann Clin Biochem; 2004 May; 41(Pt 3):233-6. PubMed ID: 15117439
[TBL] [Abstract][Full Text] [Related]
35. Developmental effects of petroleum creosote on mice following oral exposure.
Iyer PR; Irvin TR; Martin JE
Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):371-4. PubMed ID: 8122038
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
37. Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.
Bridges CC; Joshee L; Zalups RK
Placenta; 2009 Sep; 30(9):800-5. PubMed ID: 19615742
[TBL] [Abstract][Full Text] [Related]
38. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
[TBL] [Abstract][Full Text] [Related]
39. Metal-induced developmental toxicity in mammals: a review.
Domingo JL
J Toxicol Environ Health; 1994 Jun; 42(2):123-41. PubMed ID: 8207750
[TBL] [Abstract][Full Text] [Related]
40. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
